DALLAS–(BUSINESS WIRE)–MedCognetics, Inc. today announced it has received U.S Food and Drug Administration (FDA) 510(k) clearance of its artificial intelligence (AI)-enabled software for breast cancer screening, QmTRIAGE®. The Company is developing the next generation of AI medical imaging technology with an initial focus on improving outcomes of early breast cancer detection, particularly across a diverse […]
The post U.S. FDA Clears MedCognetics’ AI Enabled Breast Cancer Screening Software appeared first on The Black Chronicle.